Literature DB >> 12438323

Induction of keratinocyte growth factor 1 Expression by lipopolysaccharide is regulated by CD-14 and toll-like receptors 2 and 4.

Edward E Putnins1, Ali-Reza Sanaie, Qiang Wu, James D Firth.   

Abstract

Periodontal disease is a chronic inflammatory condition that is associated with increased concentrations of gram-negative pathogenic bacteria and epithelial cell proliferation. Regulation of this proliferation is poorly understood but is most likely controlled by locally expressed growth factors. Keratinocyte growth factor 1, an epithelium-specific growth factor, is expressed by gingival fibroblasts, and its expression is regulated in a concentration-dependent manner by lipopolysaccharide. In this study, induction of keratinocyte growth factor 1 protein expression was dependent on gingival fibroblast expression of membrane CD14 (mCD14) and Toll-like receptors 2 and 4. Lipopolysaccharides from Escherichia coli and Porphyromonas gingivalis induced membrane expression of CD14 at 1, 3, and 24 h. Specifically, lipopolysaccharide induced low mCD14 expression gingival fibroblasts to express mCD14 at a level consistent with that of high mCD14 expression cells. Functional studies with specific blocking antibodies for CD14 and Toll-like receptors 2 and 4 implicated all of these molecules in signal transduction. The rapid decrease in cell membrane expression of Toll-like receptors 2 and 4 after treatment with lipopolysaccharide was consistent with receptor internalization, and blocking of either of these receptors completely inhibited keratinocyte growth factor 1 protein expression. The transcription factors AP-1 and NF-kappaB were involved in lipopolysaccharide induction of keratinocyte growth factor 1 mRNA and protein expression. These results suggest that lipopolysaccharide may induce proliferation of periodontal epithelial cells by upregulating keratinocyte growth factor 1 expression via the CD14 and Toll-like receptor signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438323      PMCID: PMC132971          DOI: 10.1128/IAI.70.12.6541-6548.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  60 in total

1.  Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin.

Authors:  A M Hajjar; D S O'Mahony; A Ozinsky; D M Underhill; A Aderem; S J Klebanoff; C B Wilson
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

Review 2.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

3.  Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts.

Authors:  K Tabeta; K Yamazaki; S Akashi; K Miyake; H Kumada; T Umemoto; H Yoshie
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

Review 4.  The Toll receptor family.

Authors:  M Muzio; A Mantovani
Journal:  Allergy       Date:  2001-02       Impact factor: 13.146

5.  The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors.

Authors:  A Ozinsky; D M Underhill; J D Fontenot; A M Hajjar; K D Smith; C B Wilson; L Schroeder; A Aderem
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2.

Authors:  M Hirschfeld; Y Ma; J H Weis; S N Vogel; J J Weis
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

Review 7.  Structure and function of Toll-like receptor proteins.

Authors:  T K Means; D T Golenbock; M J Fenton
Journal:  Life Sci       Date:  2000-12-08       Impact factor: 5.037

8.  Gene expressions of lipopolysaccharide receptors, toll-like receptors 2 and 4, are differently regulated in mouse T lymphocytes.

Authors:  T Matsuguchi; K Takagi; T Musikacharoen; Y Yoshikai
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

9.  Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses.

Authors:  D H Wyllie; E Kiss-Toth; A Visintin; S C Smith; S Boussouf; D M Segal; G W Duff; S K Dower
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

10.  Involvement of CD14 on human gingival fibroblasts in Porphyromonas gingivalis lipopolysaccharide-mediated interleukin-6 secretion.

Authors:  P L Wang; K Sato; M Oido; T Fujii; Y Kowashi; M Shinohara; K Ohura; H Tani; Y Kuboki
Journal:  Arch Oral Biol       Date:  1998-09       Impact factor: 2.633

View more
  4 in total

1.  Association of CD14-260 polymorphisms, red-complex periodontopathogens and gingival crevicular fluid cytokine levels with cyclosporine A-induced gingival overgrowth in renal transplant patients.

Authors:  Y Gong; W Bi; L Cao; Y Yang; J Chen; Y Yu
Journal:  J Periodontal Res       Date:  2012-08-31       Impact factor: 4.419

2.  Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4.

Authors:  Richard P Darveau; Thu-Thao T Pham; Kayde Lemley; Robert A Reife; Brian W Bainbridge; Stephen R Coats; William N Howald; Sing Sing Way; Adeline M Hajjar
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

3.  Membrane-anchored CD14 is important for induction of interleukin-8 by lipopolysaccharide and peptidoglycan in uroepithelial cells.

Authors:  Toshiaki Shimizu; Shin-ichi Yokota; Satoshi Takahashi; Yasuharu Kunishima; Koh Takeyama; Naoya Masumori; Atsushi Takahashi; Masanori Matsukawa; Naoki Itoh; Taiji Tsukamoto; Nobuhiro Fujii
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

4.  The toll-like receptor signaling molecule Myd88 contributes to pancreatic beta-cell homeostasis in response to injury.

Authors:  Paul L Bollyky; Jeffrey B Bice; Ian R Sweet; Ben A Falk; John A Gebe; April E Clark; Vivian H Gersuk; Alan Aderem; Thomas R Hawn; Gerald T Nepom
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.